ArticleJournal for immunotherapy of cancer2022

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).

Michael B Atkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.